8 completed, 2 terminated, 1 recruiting, 1 unknown. 12 Phase 2, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 8, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 3 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow Transient Ischemic Attack: new trials by email Literature Review of Transient Ischemic Attack trials Research Report on Transient Ischemic Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| European Blood Pressure Intensive Control After Stroke anti-hypertensive, home blood pressure measurement, telemonitoring and medication titration, Standard of Care Blood Pressure Management with Antihypertensives - Ischemic Stroke, Transient Ischemic Attack | Phase 2 | Unknown | University College Dublin | 142 | 2024-05-02 | 2024-07-11 |
| Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke Ticagrelor 60 + Aspirin, Ticagrelor 90 + aspirin - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Recruiting | Mazandaran University of Medical Sciences | 100 | 2024-04-01 | 2025-04-27 |
| Dabigatran Following Transient Ischemic Attack and Minor Stroke Dabigatran, Acetylsalicylic acid - Transient Ischemic Attack, Minor Ischemic Stroke | Phase 2 | Completed | University of Alberta | 300 | 2015-01-01 | 2019-01-30 |
| Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation Rivaroxaban, Warfarin - Ischemic Stroke, Transient Ischemic Attack | Phase 2 | Completed | Asan Medical Center | 195 | 2014-01-01 | 2017-02-08 |
| Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke Dabigatran 110/150 mg BID - Transient Ischemic Attack, Minor Ischemic Stroke | Phase 2 | Completed | University of Alberta | 53 | 2012-02-01 | 2014-10-30 |
| Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT PREVENT program, Usual Care - Transient Ischemic Attack, Non-disabling Stroke | Phase 2 | Completed | Marilyn MacKay-Lyons | 187 | 2011-10-30 | 2018-03-23 |
| Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 225 | 2008-12-23 | 2017-06-14 |
| VISSIT Intracranial Stent Study for Ischemic Therapy Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy) - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Terminated | Codman & Shurtleff | 125 | 2008-10-01 | 2015-02-20 |
| Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables Levosimendan, Placebo - Transient Ischemic Attack, Stroke | Phase 2 | Completed | Orion Corporation, Orion Pharma | 32 | 2008-08-01 | 2009-11-25 |
| Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack auto-titrating continuous positive airway pressure - Transient Ischemic Attack, Sleep Apnea | Phase 2 | Completed | Yale University | 62 | 2004-11-01 | 2009-03-03 |
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) Aspirin, Clopidogrel, Simvastatin - Transient Ischemic Attack, Stroke | Phase 2 / Phase 3 | Completed | University of Calgary | 500 | 2003-05-01 | 2008-04-08 |
| E-Selectin Nasal Spray to Prevent Stroke Recurrence E-Selectin nasal spray - Cerebrovascular Accident, Transient Ischemic Attack | Phase 2 | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 60 | 2001-03-01 | 2010-05-04 |
Ischemic Attack, Transient (12) · Stroke (6) · Ischemic Stroke (4) · Hypertension (2) · Recurrence (2) · Sleep Apnea Syndromes (2) · Brain Ischemia (1) · Camurati-Engelmann Syndrome (1) · Motor Activity (1) · Myocardial Infarction (1) · Sleep Apnea, Obstructive (1)
Brain Diseases (12) · Cardiovascular Diseases (12) · Central Nervous System Diseases (12) · Cerebrovascular Disorders (12) · Nervous System Diseases (12) · Vascular Diseases (12) · Brain Ischemia (11) · Stroke (3) · Apnea (2) · Disease Attributes (2) · Dyssomnias (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2)
Aspirin (4) · Clopidogrel (2) · Dabigatran (2) · Antihypertensive Agents (1) · BID protein, human (1) · Rivaroxaban (1) · Simendan (1) · Simvastatin (1) · Warfarin (1)
University of Alberta (2) · Asan Medical Center (1) · Codman & Shurtleff (1) · Marilyn MacKay-Lyons (1) · Mazandaran University of Medical Sciences (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Orion Corporation, Orion Pharma (1) · University College Dublin (1) · University of Calgary (1) · VA Office of Research and Development (1) · Yale University (1)
Canada (4) · United States (4) · Finland (1) · Germany (1) · Hungary (1) · Iran (1) · Ireland (1) · South Korea (1) · Sweden (1)
Alastair M Buchan (1) · Byung-Woo Yoon, PhD (1) · Dawn M Bravata, MD (1) · Dawn M. Bravata, MD (1) · Eung-Gyu Kim, PhD (1) · Irja Korpela (1) · Jaekwan Cha, PhD (1) · James Kennedy (1) · Keun-Sik Hong, PhD (1) · Kyung-Ho Yu, PhD (1) · Marilyn MacKay-Lyons, PhD (1) · Risto O. Roine, M.D., Ph.D. (1) · Sun Uck Kwon, PhD. (1) · Woo-Keun Seo, PhD (1) · Yang Ha Hwang, PhD (1)
PMID 17931979, PMID 21143864, PMID 21885958, PMID 22334806, PMID 22968110, PMID 24458967, PMID 25346499, PMID 25803346, PMID 26082815, PMID 26304866, PMID 28585903, PMID 28892526, PMID 32098609, PMID 34788569, PMID 36398903, PMID 36907985, PMID 39788764